EX-23.1 3 tm2232281d1_ex23-1.htm EXHIBIT 23.1

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

Checkpoint Therapeutics, Inc.

Waltham, MA

 

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated March 28, 2022, relating to the financial statements of Checkpoint Therapeutics, Inc. appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.

 

/s/ BDO USA, LLP

 

New York, New York

 

December 9, 2022